Keros Therapeutics, Inc. (KROS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 757.82M |
| Enterprise Value | 487.29M |
| P/E Ratio | -2.98 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 23.51 |
| Price/Book Ratio | 0.83 |
| Enterprise/Revenue | 7.4 |
| Enterprise/EBITDA | -1.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -5.54 |
| Operating Margin | -6.76 |
| Return On Assets | -0.29 |
| Return On Equity | -0.21 |
| Revenue | 244.06M |
| Revenue/Share | 0.76 |
| Gross Profit | 242.55M |
| EBITDA | 93.41M |
| Net Income | 87.01M |
| Diluted EPS | 2.3 |
| Total Cash | 257.61M |
| Total Cash/Share | 13.01 |
| Total Debt | 15.72M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 21.96 |
| Book Value Per Share | 13.25 |
| 52-Week Change | -29.11 |
| 52-Week High | 22.55 |
| 52-Week Low | 9.69 |
| Moving Average 50 Days | 10.67 |
| Moving Average 200 Days | 13.93 |
| Average Volume | 251,687 |
| Shares Outstanding | 32M |
| % Held by Institutions | 49.96 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |